Apart from TNF-α inhibition, we also performed neutralization with GMCSF monoclonal antibody, which did not display any changes in the pro-inflammatory cytokine secretion in the T2DM patients, but a significant decrease in IL-4 was observed (Figure 4C). The gene discussed is CSF2; the disease is type 2 diabetes mellitus.